XML 67 R56.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Balance Sheet Components - Schedule of Accrued and Other Current Liabilities (Detail) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Accrued Liabilities, Current [Abstract]    
Preclinical and clinical trial accruals $ 26,397 $ 27,663
API and bulk drug product price true-up 57,370 50,978
Litigation settlement 28,500 28,500
Payroll and related accruals 7,398 20,267
Inventory cost related 8,521 0
Accrued co-promotion expenses - current 11,425 10,309
Roxadustat profit share to AstraZeneca 6,952 7,084
Property taxes and other taxes 7,346 6,615
Professional services 4,711 7,103
Current portion of liability related to sale of future revenues 1,213 5,654
Accrued restructuring charge 0 3,697
Other 4,453 5,021
Total accrued and other current liabilities $ 164,286 $ 172,891